Poor response correlates with advanced age, high BMI, comorbid autoimmune diseases, low total IgE (<40–50 IU/ml), positivity for ANA or anti-TPO antibodies, and activation markers such as CD203c. Here, ENPP3 is linked to autoimmune disease.